“INTEGRATing patient reported outcomes, clinical data and quality indicators to physician drive data in clinical management of chronic rheumatic diseases: the paradigm of Systemic Lupus Erythematosus”

You may recall a request from Lupus Europe, on behalf of the Integrate Project, to complete an on-line survey. Over 750 people completed the questionnaire which is a fabulous achievement so a huge thank you to those who were able to contribute; it makes a significant difference to this or any other research. 20 members were selected to participate in a face to face focus group weekend in Pisa during the weekend of 1-3 March 2019. Participants were selected based on their clinical history and combination of symptoms so as to portray a wide experience of living with Lupus.

The INTEGRATE project, coordinated by Prof. Marta Mosca from the Rheumatology Unit, Department of Clinical and Experimental Medicine of the University of Pisa (Italy), started on 1st of September 2017 and will last two years. Consortium is composed by three partners from Italy and Germany and involves players from university hospitals and academia.

The main aim of INTEGRATE is the development of a strategy for the monitoring and treatment of chronic diseases relying on the integration of Quality of Life data, Patient Reported Outcomes, and other patient driven data to the traditional evaluation. The INTEGRATE Project was co-funded by the European Union’s Health Programme (2014-2020) (*)

The first evening was an opportunity to relax from the travelling and meet altogether for the first time. There certainly was variety in the group; patients/people with Lupus and professionals new and old (time not age!) Lupus Europe members, warriors starting their journey and those who’ve been around the block more times than they care to remember, tales of experiences both positive and  challenging, tips, tricks and so much more. In essence and already with only light conversation to witness, the crucial sharing – and exchange – had truly begun….

The itinerary had been sent in advance but we can presume that a huge A2 copy in the hotel foyer was worth it’s weight in gold! The weekend would be a combination of focus groups, physiotherapy, discussion and importantly, time for us to rest and recharge. Even so, the details and arrangements were all taken care of by a team of dedicated staff. Everybody was escorted to the St. Anna School for the first day. En route, another chance to meet other participants and hear experiences.

Scuola Superiore Sant’Anna (St. Anna school of Advanced Studies) is stunning. They say never judge a book by it’s cover but with one look at the surroundings on approach, already a sense of excellence could be felt. Absolutely, it is never about the exterior but certain that  as keen as participants were to get inside, the hosts were equally excited to welcome everybody in to begin the work. This stunning learning environment was waiting for us to take our seats. Everybody walking in awe to the lecture room. Lecture room? Try fresco painted walls, traditional patio doors, carvings, views to ancients artefacts, sculptures, banana trees. Banana trees!

For the duration, people were split between focus group and physiotherapy sessions. The aim of the Focus Group was to take the on-line survey responses and delve further for a deeper understanding. Clinicians and researchers were not allowed to be present. Any researches that did enter the space, were there to ensure transparency, did not comment and therefor could not influence responses.   It’s always fascinating how even in small groups, opinions can differ yet all so valid. The facilitator was able to hold fairly all perspectives and will amalgamate these for the final summary, hopefully published May 2019.

During the physio activity, exercises demonstrated were simple, gentle and a proven method to improve muscle strength and joint mobility. Many people shared their exercise solutions and hurdles but we will ignore the participants who thought the water bottles were for alternative weights not drinking! This was a privilege to be shown and advised by a Lupus-aware expert and received comments such as, ‘this is like a private class!’. The insertion and scheduling within the programme to ‘move’ was a perfect balance.

Beautiful Pisa. The town has blended the traditional with the new but as the project is located within the Old Town, one couldn’t help but consider and be immersed in the rich history all around. Wikipedia  says,

Pisa (/ˈpiːzə/; Italian: [ˈpiːza], locally also [ˈpiːsa]) is a city and comune in Tuscany, central Italy, straddling the Arno just before it empties into the Ligurian Sea. It is the capital city of the Province of Pisa. Although Pisa is known worldwide for its leaning tower (the bell tower of the city’s cathedral), the city of over 91,104 residents (around 200,000 with the metropolitan area) contains more than 20 other historic churches, several medieval palaces, and various bridges across the Arno. Much of the city’s architecture was financed from its history as one of the Italian maritime republics.

The city is also home of the University of Pisa, which has a history going back to the 12th century and also has the Scuola Normale Superiore di Pisa, founded by Napoleon in 1810, and its offshoot, the Sant’Anna School of Advanced Studies, as the best-sanctioned Superior Graduate Schools in Italy. Students are admitted after passing public national and international competitions. Sant’Anna School of Advanced Studies offers to those who decide to take excellence, a multi-disciplinary approach to learning, research, and internationalization.

But what is a place without it’s people? The steering force and passion of the Integrate Team is highly motivational, their enthusiasm infectious. The combination of these qualities aligned with the commitment and desire from participants, resulted in a much-needed way of working. No hierarchy, no preconceived ideas, no judgements simply a willingness to pioneer and prove a new way to partner for successful Lupus healthcare. Knowing these people are dedicating their work for the benefit of the hundreds and thousands of people living with Lupus is humbling. And for that, an acknowledgement of thanks to all, notably, Prof. Dr. Marta Mosca (University of Pisa, Department of Clinical and Experimental Medicine), Prof. Giuseppe Turchetti (Sant’Anna School of Advanced Studies, Institute of Management), Prof. Dr. Matthias Schneider (Heinrich-Heine-University Düsseldorf, Policlinic of Rheumatology & Hiller Research Unit) and all project associated staff.  Last but not least, Lupus Europe and member organisations for actively making a difference for people now and in the future.  Thank you – your commitment truly matters.

 

(*)  project website at https://www.integrate-sle.eu

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

💜 We've taken part in the EULAR PARE Conference 2026 in Brussels! And what an interesting opportunity to discuss the future of AI in healthcare!

🌍 Bringing together more than 100 delegates and speakers from across Europe and beyond, the conference explored some of the most important questions surrounding artificial intelligence in rheumatology and patient advocacy.

From the opportunities and risks of AI to health inequalities, accessibility and European health policy, the discussions highlighted why patient perspectives must be part of the conversation.

🤩 We were particularly proud to see Jeanette Andersen, Chair of the Lupus Europe Board, sharing our experience with #LupusGPT in her presentation, “AI as a Partner in Care: Empowering the RMD Community with Information”.

💡 Jeanette explained how #LupusGPT was developed with patients and clinicians to offer free, multilingual access to reliable lupus information based on validated sources.

She also introduced #EasyLupus, which provides the same trusted information in simpler language, highlighting why accessibility must be considered when developing AI tools.

But one of the most important messages from her presentation went beyond technology.

💜 Patient organisations have much more to contribute to AI than simply using tools developed by others.

As Jeanette highlighted, patient organisations bring lived experience, knowledge of unmet needs, trusted information and an understanding of the barriers people face when accessing health information.

Technology alone cannot tell us what patients really need or what makes a tool genuinely useful.

Patients and patient organisations should not simply be users of AI. They should help shape its development.

👏 A big thank you to EULAR PARE for bringing together so many different perspectives and creating space for meaningful discussions about the future of healthcare and patient involvement!
...

💜 Weve taken part

🦋 One of the greatest strengths of patient organisations is the support, understanding and sense of community they offer to people living with lupus. 💜

🇧🇬 A great example comes from Организация на пациентите с ревматологични заболявания, who shared their psychological support initiative at the #LupusConvention!

💜 Launched in December 2025, this pilot project provides a safe and supportive space where participants can share their experiences and discuss the challenges of living with lupus, from fatigue and anxiety to relationships and everyday life.

👥 Led by a clinical psychologist, the group currently brings together six women. The project is expected to run until December 2026, while the organisation explores funding opportunities to continue and expand the initiative.

Thank you to our Bulgarian colleagues for sharing their experience, and congratulations on the amazing job you are doing! ❤️

🌍 This is just one example of the valuable work patient organisations are doing across Europe, often responding to needs that go beyond medical care. We'll share more in the coming days!

💜 Are you living with lupus? You don't have to navigate everything alone! Your national lupus organisation may offer information, support, activities and opportunities to connect with others who understand your experiences.

🔗 Find your national lupus organisation and get in touch:
lupus-europe.org/lupus-members/
...

Image attachment
Image attachment

💜 Young people living with lupus are not only the future of patient advocacy. Their voices matter today!

On 23 and 24 October, LUPUS EUROPE was delighted to be represented at the first 𝗘𝗣𝗙 𝗬𝗼𝘂𝘁𝗵 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟲 in Brussels by Ana Rita Vieira, from the LUPUS EUROPE Youth Group, and Lena Koskina, LUPUS EUROPE's Youth Group Coordinator.

🌍 Organised by European Patients' Forum and its EPF Youth Group, the Congress brought together young patient advocates from across Europe to explore the challenges facing young people living with chronic conditions, from economic uncertainty and climate change to the barriers they encounter when trying to influence healthcare decisions.

🌟 One particularly important question ran through the discussions: 𝗵𝗼𝘄 𝗱𝗼 𝘄𝗲 𝗺𝗼𝘃𝗲 𝗯𝗲𝘆𝗼𝗻𝗱 𝘀𝗶𝗺𝗽𝗹𝘆 𝗴𝗶𝘃𝗶𝗻𝗴 𝘆𝗼𝘂𝗻𝗴 𝗽𝗲𝗼𝗽𝗹𝗲 𝗮 𝘀𝗲𝗮𝘁 𝗮𝘁 𝘁𝗵𝗲 𝘁𝗮𝗯𝗹𝗲, 𝗮𝗻𝗱 𝗲𝗻𝘀𝘂𝗿𝗲 𝘁𝗵𝗲𝘆 𝗵𝗮𝘃𝗲 𝗮 𝗿𝗲𝗮𝗹 𝘀𝗮𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝗯𝗲𝗶𝗻𝗴 𝗺𝗮𝗱𝗲❓

The conversations also highlighted something easily overlooked: 𝗺𝗲𝗮𝗻𝗶𝗻𝗴𝗳𝘂𝗹 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝘀 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗮𝗻 𝗶𝗻𝘃𝗶𝘁𝗮𝘁𝗶𝗼𝗻. Young people living with chronic conditions are often balancing their health with education, employment and financial pressures. Advocacy opportunities need to recognise those realities, and not be accessible only to those who can afford the time and resources to participate.

🦋 At LUPUS EUROPE, supporting the Youth Group means actively helping create those opportunities, connecting young advocates with others across Europe and ensuring their perspectives can meaningfully contribute to the work we do.

Young people living with lupus are already advocates, bringing their experiences, ideas and knowledge into conversations that matter.

💜 Thank you to European Patients' Forum and its EPF Youth Group for bringing everyone together, and to Rita and Lena for representing LUPUS EUROPE at this important Congress!
...

💜 Young people li

🔊 Hot off the press!

💜 Treatment adherence is important, complex and multifactorial.

But understanding the importance of treatment adherence is not the same as knowing how to support it in everyday clinical practice.

That’s why, in 2020, EULAR published its Points to Consider for the prevention, screening, assessment and management of nonadherence to treatment in people with rheumatic and musculoskeletal diseases.

But having recommendations is only the first step. How can we ensure they become part of everyday clinical practice?

🤩 An interesting new viewpoint published in EULAR Rheumatology Open, co-authored by Jeanette Andersen, Chair of the Lupus Europe Board, now explores the challenges of putting these recommendations into routine rheumatology care.

The article highlights that nonadherence is not simply a matter of individual patient behaviour. Concerns about treatment, practical difficulties, access to medication, socioeconomic circumstances and communication with healthcare professionals can all play a role.

The authors highlight five key priorities for putting adherence support into routine rheumatology practice:

🔹 Assessment: Identifying adherence behaviours and the barriers behind them.
🔹 Monitoring: Reassessing adherence over time, as it may change throughout the disease course.
🔹 Shared decision-making: Discussing patients’ preferences, expectations and concerns through non-judgemental communication.
🔹 Multidisciplinary care: Involving the wider healthcare team according to individual needs.
🔹 Training: Making adherence support part of rheumatology education and professional development.

💜 The challenge is not the lack of recommendations, but making adherence assessment and support a routine part of rheumatology care.

📖 Read the open-access viewpoint: doi.org/10.1016/j.ero.2026.100261
...

Image attachment
Image attachment
Image attachment
Image attachment
LUPUS EUROPE Uniting people with Lupus throughout Europe
Send